Moreover, agents that enhance heme oxygenase-1 activity and increase Nrf2 levels in experimentally induced colitis were reported to reduce ROS production, possibly via suppression of NF-κB activity and inhibition of iNOS expression in the colonic tissues [30]. Here, NFKB1 is linked to colitis.